These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 32543879)

  • 61. Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling.
    McAllister CS; Ansaldi D; Growcott EJ; Zhong Y; Quackenbush D; Wolff KC; Chen Z; Tanaseichuk O; Lelais G; Barnes SW; Federe GC; Luna F; Walker JR; Zhou Y; Kuhen KL
    Virology; 2020 Jan; 540():195-206. PubMed ID: 31929001
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characterization of the role of N-glycosylation sites in the respiratory syncytial virus fusion protein in virus replication, syncytium formation and antigenicity.
    Leemans A; Boeren M; Van der Gucht W; Martinet W; Caljon G; Maes L; Cos P; Delputte P
    Virus Res; 2019 Jun; 266():58-68. PubMed ID: 31004621
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification and evaluation of a novel tribenzamide derivative as an inhibitor targeting the entry of the respiratory syncytial virus.
    Issmail L; Ramsbeck D; Jäger C; Henning T; Kleinschmidt M; Buchholz M; Grunwald T
    Antiviral Res; 2023 Mar; 211():105547. PubMed ID: 36682463
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association of Viral Load With Disease Severity in Outpatient Children With Respiratory Syncytial Virus Infection.
    Uusitupa E; Waris M; Heikkinen T
    J Infect Dis; 2020 Jun; 222(2):298-304. PubMed ID: 32067050
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antiviral and Immunomodulatory Activity of Silver Nanoparticles in Experimental RSV Infection.
    Morris D; Ansar M; Speshock J; Ivanciuc T; Qu Y; Casola A; Garofalo R
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31398832
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Analysis of respiratory syncytial virus fusion protein from clinical isolates of Korean children in palivizumab era, 2009-2015.
    Choi SH; Park KS; Kim YJ
    J Infect Chemother; 2019 Jul; 25(7):514-519. PubMed ID: 30885457
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of the expression level of 12/15 lipoxygenase and the related inflammatory factors (CCL5, CCL3) in respiratory syncytial virus infection in mice model.
    Salimi V; Ramezani A; Mirzaei H; Tahamtan A; Faghihloo E; Rezaei F; Naseri M; Bont L; Mokhtari-Azad T; Tavakoli-Yaraki M
    Microb Pathog; 2017 Aug; 109():209-213. PubMed ID: 28579398
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Role of Viral Load and Host Cytokines in Determining the Disease Severity of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Tract Infections in Children.
    Sarkar S; Ratho RK; Singh M; Singh MP; Singh A; Sharma M
    Jpn J Infect Dis; 2023 Jul; 76(4):233-239. PubMed ID: 37005272
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Low peripheral blood chemokine (C-C motif) ligand 5 and tumor necrosis factor α gene expression is associated with unfavorable progression of respiratory syncytial virus bronchiolitis in infants.
    Pita-Martínez C; Goez-Sanz C; Virseda-Berdices A; Gonzalez-Praetorius A; Mazario-Martín E; Rodriguez-Mesa M; Amigot-Sánchez R; Matías V; Resino S; Martínez I
    Int J Infect Dis; 2024 Jan; 138():97-101. PubMed ID: 38008352
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antiviral activity of extracellular vesicles derived from respiratory syncytial virus-infected airway epithelial cells.
    Corsello T; Qu Y; Ivanciuc T; Garofalo RP; Casola A
    Front Immunol; 2022; 13():886701. PubMed ID: 36032066
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus.
    Tian P; Wang Y; Liu H; Yang Y; Wu X; Wei H; Chen T
    Front Cell Infect Microbiol; 2019; 9():275. PubMed ID: 31417879
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mucosal gene expression vaccine: a novel vaccine strategy for respiratory syncytial virus.
    Mohapatra SS
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S100-3; discussion S103-4. PubMed ID: 12671460
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Co-Circulation of 72bp Duplication Group A and 60bp Duplication Group B Respiratory Syncytial Virus (RSV) Strains in Riyadh, Saudi Arabia during 2014.
    Ahmed A; Haider SH; Parveen S; Arshad M; Alsenaidy HA; Baaboud AO; Mobaireek KF; AlSaadi MM; Alsenaidy AM; Sullender W
    PLoS One; 2016; 11(11):e0166145. PubMed ID: 27835664
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Marked induction of matrix metalloproteinase-10 by respiratory syncytial virus infection in human nasal epithelial cells.
    Hirakawa S; Kojima T; Obata K; Okabayashi T; Yokota S; Nomura K; Obonai T; Fuchimoto J; Himi T; Tsutsumi H; Sawada N
    J Med Virol; 2013 Dec; 85(12):2141-50. PubMed ID: 24009192
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice.
    Tahamtan A; Samieipoor Y; Nayeri FS; Rahbarimanesh AA; Izadi A; Rashidi-Nezhad A; Tavakoli-Yaraki M; Farahmand M; Bont L; Shokri F; Mokhatri-Azad T; Salimi V
    Virulence; 2018 Jan; 9(1):217-230. PubMed ID: 28992427
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neutrophils do not impact viral load or the peak of disease severity during RSV infection.
    Kirsebom F; Michalaki C; Agueda-Oyarzabal M; Johansson C
    Sci Rep; 2020 Jan; 10(1):1110. PubMed ID: 31980667
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characteristics and Their Clinical Relevance of Respiratory Syncytial Virus Types and Genotypes Circulating in Northern Italy in Five Consecutive Winter Seasons.
    Esposito S; Piralla A; Zampiero A; Bianchini S; Di Pietro G; Scala A; Pinzani R; Fossali E; Baldanti F; Principi N
    PLoS One; 2015; 10(6):e0129369. PubMed ID: 26047100
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Human respiratory syncytial virus infection is inhibited by IFN-induced transmembrane proteins.
    Zhang W; Zhang L; Zan Y; Du N; Yang Y; Tien P
    J Gen Virol; 2015 Jan; 96(Pt 1):170-182. PubMed ID: 25228491
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hydrogen Sulfide Is an Antiviral and Antiinflammatory Endogenous Gasotransmitter in the Airways. Role in Respiratory Syncytial Virus Infection.
    Ivanciuc T; Sbrana E; Ansar M; Bazhanov N; Szabo C; Casola A; Garofalo RP
    Am J Respir Cell Mol Biol; 2016 Nov; 55(5):684-696. PubMed ID: 27314446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.